Top Story

Prostate Cancer 400
MRI
MRI could replace DRE for prostate cancer staging
MRI showed comparable performance to DRE in prostate cancer staging without compromising patient outcomes.
Featured
A normal mammogram confirmed by three-year radiologic follow-up illustrates reader-marked regions of interest (ROIs) during (A) unaided (round 1) and (B) artificial intelligence (AI)–assisted (round 2) reading. Each colored dot represents an ROI for recall by a human reader. Readers could mark more than one ROI per case, represented by multiple dots of the same color. During AI-assisted reading, the AI system displayed three visible prompts: two with suspicion of malignancy scores of 35% (left mediolateral oblique [L MLO] and craniocaudal [L CC]) and one with a suspicion of malignancy score of 10% (right craniocaudal [R CC]), shown as polygonal overlays. Without AI, six of 10 readers (60%) marked a false-positive ROI. With AI assistance, this fell to two of 10 (20%). R MLO = right mediolateral oblique.
Womens Imaging
Incorrect AI suggestions influence reader performance on mammography
Iodinated contrast media are among the most commonly administered agents in radiology.
CT
Large Korean study adds evidence on contrast media hypersensitivity
Latest News
Voxel-based morphometry (VBM) group comparison of grey matter brain volumes. TFCE-corrected significance map shown (one-tailed t-test; higher significance indicated by light blue color). (a) Comparison between ex-soccer players (n = 124) and controls (n = 40). (b) Comparison between ex-rugby players (n = 200) and controls (n = 33) from Graham & Zimmerman et al. (2025), reproduced with permission under Creative Commons license.
MRI shows higher neuro symptom burden for former football players
July 13, 2026
Surgeon performs a carotid artery procedure.
German registry shows sharp rise in carotid artery stenting as CREST-2 reshapes prevention
July 13, 2026
MRI false positive for additional disease, (top to bottom): A. Index lesion—grade 2 invasive ductal carcinoma; B. MRI lesion two, upper inner quadrant: Stromal sclerosis and columnar cell change; C. MRI lesion three, upper outer quadrant: No ultrasound correlate, no malignancy on follow-up; D. CEM marked background parenchymal enhancement with a unifocal retroareolar lesion demonstrating wash-out on delayed MLO. Images are republished under a Creative Commons license (CC BY 4.0).
CEM on par with MRI for breast cancer diagnosis, local staging
July 10, 2026
Cancer Target
New PET tracer show promise in neuroblastoma
July 9, 2026
Cases of the Week
Check out our Cases of the Week!
32-year-old man with subacute left jaw pain revisited
A 32-year-old man presented to clinic for subacute left “jaw pain.”
40-year-old man undergoing x-ray after placement of pacemaker revisted
39-year-old man with orbital proptosis, possible orbital mass revisited
View All Cases
Prostate Cancer 400
MRI
MRI could replace DRE for prostate cancer staging
Womens Imaging
Incorrect AI suggestions influence reader performance on mammography
CT
Large Korean study adds evidence on contrast media hypersensitivity
MRI
MRI shows higher neuro symptom burden for former football players
Womens Imaging
CEM on par with MRI for breast cancer diagnosis, local staging
Who's paying, and for what, is the question that actually decides whether AI in healthcare gets funded.
AI
The cost of AI, and finding its breakeven point
AI
AI aims to decode targeted radiotherapy response
AI
RCR: Agentic AI is off the leash, and already a workhorse for health systems
AI
Most patients want to know if AI being used for imaging reports
AI
More work than relief: AI in the wrong seat, RCR census finds
Siemens2
Radiation Oncology/Therapy
Siemens to invest €70 million to expand site in Germany
Industry News
Actineer completes Ra-226 recycling process to support Ac-225 supply
Ultrasound
HistoSonics gets CE Mark for histotripsy system
Industry News
Blue Earth, UCL dose first patient in Ac-225 PSMA prostate trial
Industry News
Philips launches new ultrasound system
More from AuntMinnieEurope
Siemens to invest €70 million to expand site in Germany
By AuntMinnieEurope.com staff writers
The hall will have a total floor area of about 4,500 square meters, including 3,400 square meters of production space for radiotherapy components.
July 15, 2026
Siemens2
Actineer completes Ra-226 recycling process to support Ac-225 supply
By AuntMinnie.com staff writers
This process aims to improve Ac-225 supply predictability and cost stability, as well as reduce waste generation.
July 14, 2026
Nuclear Medicine Worker Sm
HistoSonics gets CE Mark for histotripsy system
By AuntMinnie.com staff writers
The system uses histotripsy, a noninvasive focused ultrasound technology that mechanically destroys liver tumors without surgery, needles, radiation, or heat.
July 13, 2026
Histosonics System (2) (1) (1)
The cost of AI, and finding its breakeven point
By Claudia Tschabuschnig
Who pays, what, where, and when: speakers at the Royal College of Radiologists' Global AI Conference dug into what AI actually costs and when, if ever, it pays for itself.
July 9, 2026
Who's paying, and for what, is the question that actually decides whether AI in healthcare gets funded.
Blue Earth, UCL dose first patient in Ac-225 PSMA prostate trial
By AuntMinnie.com staff writers
The study is evaluating an investigational alpha-emitting PSMA-targeted radiopharmaceutical in prostate cancer patients.
July 9, 2026
Blue Earth Therapeutics Logo
AI aims to decode targeted radiotherapy response
By Claudia Tschabuschnig
Same administered activity, different results. Speakers at the Royal College of Radiologists’ 2nd Annual Global AI Conference argued AI could help move targeted radionuclide therapy beyond a one-size-fits-all approach toward more precise, personalized treatment.
July 8, 2026
Experts at the Royal College of Radiologists’ 2nd Annual Global AI Conference discussed how AI could help move cancer care toward more personalized treatment, from targeted radionuclide therapy dosing to drug discovery.
Philips launches new ultrasound system
By AuntMinnie.com staff writers
The system features AI-powered workflows and is designed for high-volume clinical environments.
July 8, 2026
Alturion
Imagion extends collaboration with Siemens on MRI contrast agent
By AuntMinnie.com staff writers
Siemens will provide in-kind expertise and technical support to clinical sites.
July 8, 2026
Ai Handshake
RCR: Agentic AI is off the leash, and already a workhorse for health systems
By Claudia Tschabuschnig
The technical crowd took the stage at the 2nd Annual Global AI Conference in London last week, to show radiologists where agentic AI is running, how it operates across a spread of autonomy, and why only the highest tiers demand serious governance.
July 7, 2026
Dr. Rowland Illing, chief medical officer at Amazon Web Services (AWS) and a former interventional radiologist.
Median gets CE marking for lung cancer screening software
By AuntMinnie.com staff writers
The CE marking follows the U.S. Food and Drug Administration (FDA)'s 510(k) clearance of eyonis LCS in February.
July 6, 2026
Lung Cancer
PET/MRI can reduce the need for biopsies in prostate cancer
By Will Morton
Prostate biopsies are associated with considerable morbidity, including pain, rectal bleeding, prostatitis, and urinary tract infections.
July 2, 2026
A visual abstract of the study.
Quibim launches AI breast MRI tool across Europe, UK
By AuntMinnieEurope.com staff writers
The tool, QP-Breast, highlights suspicious areas on MRI and generates reports from imaging findings.
July 2, 2026
Qp Breast Press 02